Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.

Nakai Y, Anai S, Onishi S, Masaomi K, Tatsumi Y, Miyake M, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Photodiagnosis Photodyn Ther. 2015 Jan 13. pii: S1572-1000(14)00173-2. doi: 10.1016/j.pdpdt.2014.12.010. [Epub ahead of print]

PMID:
25595357
2.

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Tanaka N, Torimoto K, Asakawa I, Miyake M, Anai S, Hirayama A, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2014 Dec 29;9(1):1163. [Epub ahead of print]

3.

Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.

Nozawa M, Ohzeki T, Tamada S, Hongo F, Anai S, Fujimoto K, Miki T, Nakatani T, Fukasawa S, Uemura H.

Int J Clin Oncol. 2014 Oct 25. [Epub ahead of print]

PMID:
25342378
4.

Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study.

Miyake M, Tanaka N, Asakawa I, Morizawa Y, Anai S, Torimoto K, Aoki K, Yoneda T, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2014 Oct 20;9:208. doi: 10.1186/1748-717X-9-208.

5.

A patient with medulloblastoma in its early developmental stage.

Shinojima N, Nakamura H, Tasaki M, Kameno K, Anai S, Iyama K, Ando Y, Seto H, Kuratsu J.

J Neurosurg Pediatr. 2014 Dec;14(6):615-20. doi: 10.3171/2014.8.PEDS13590. Epub 2014 Oct 10.

PMID:
25303160
6.

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.

Nakai Y, Anai S, Kuwada M, Miyake M, Chihara Y, Tanaka N, Hirayama A, Yoshida K, Hirao Y, Fujimoto K.

BMC Urol. 2014 Aug 3;14:59. doi: 10.1186/1471-2490-14-59.

7.

[The control of respiratory organ motion in the field of radiology: the viewpoint of a radiation oncologist].

Nakamura K, Yoshitake T, Terashima K, Sasaki T, Ohga S, Asai K, Matsumoto K, Hirata H, Shinoto M, Yoshidome S, Anai S, Shioyama Y, Honda H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2014 May;70(5):477-82. Japanese. No abstract available.

8.

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer.

Tomioka A, Tanaka N, Yoshikawa M, Miyake M, Anai S, Chihara Y, Okajima E, Hirayama A, Hirao Y, Fujimoto K.

BMC Urol. 2014 Apr 29;14:33. doi: 10.1186/1471-2490-14-33.

9.

Antitumor effect of fibrin glue containing temozolomide against malignant glioma.

Anai S, Hide T, Takezaki T, Kuroda J, Shinojima N, Makino K, Nakamura H, Yano S, Kuratsu J.

Cancer Sci. 2014 May;105(5):583-91. doi: 10.1111/cas.12397. Epub 2014 Apr 19.

PMID:
24673719
10.

Follow-up study of unilateral renal function after nephrectomy assessed by glomerular filtration rate per functional renal volume.

Hosokawa Y, Tanaka N, Mibu H, Anai S, Torimoto K, Yoneda T, Hirayama A, Yoshida K, Hayashi Y, Hirao Y, Fujimoto K.

World J Surg Oncol. 2014 Mar 19;12:59. doi: 10.1186/1477-7819-12-59.

11.

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer.

Miyake M, Nakai Y, Anai S, Tatsumi Y, Kuwada M, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Cancer Sci. 2014 May;105(5):616-22. doi: 10.1111/cas.12393. Epub 2014 Apr 6.

PMID:
24602011
12.

Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.

Shimada K, Anai S, Fujii T, Tanaka N, Fujimoto K, Konishi N.

J Pathol. 2013 Dec;231(4):495-504. doi: 10.1002/path.4271.

PMID:
24549646
13.

New treatment strategies to eradicate cancer stem cells and niches in glioblastoma.

Hide T, Makino K, Nakamura H, Yano S, Anai S, Takezaki T, Kuroda J, Shinojima N, Ueda Y, Kuratsu J.

Neurol Med Chir (Tokyo). 2013;53(11):764-72. Epub 2013 Oct 21.

14.

Can a belly board reduce respiratory-induced prostate motion in the prone position?--assessed by cine-magnetic resonance imaging.

Terashima K, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Atsumi K, Asai K, Hirakawa M, Anai S, Yoshikawa H, Honda H.

Technol Cancer Res Treat. 2013 Oct;12(5):447-53. doi: 10.7785/tcrt.2012.500334. Epub 2013 Mar 26.

PMID:
23547976
15.

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy.

Tanaka N, Asakawa I, Anai S, Hirayama A, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2013 Jan 30;8:25. doi: 10.1186/1748-717X-8-25.

16.

Phosphorylation status of Fas-associated death domain protein is associated with biochemical recurrence after radical prostatectomy.

Ikeda T, Tanaka N, Shimada K, Matsumura Y, Miyake M, Anai S, Tomioka A, Okajima E, Hirayama A, Fujimoto K, Konishi N, Hirao Y.

Urology. 2013 Mar;81(3):607-10. doi: 10.1016/j.urology.2012.11.032. Epub 2013 Jan 24.

PMID:
23352370
17.

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.

Inoue T, Anai S, Onishi S, Miyake M, Tanaka N, Hirayama A, Fujimoto K, Hirao Y.

BMC Urol. 2013 Jan 5;13:1. doi: 10.1186/1471-2490-13-1.

18.

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.

Fujii T, Shimada K, Anai S, Fujimoto K, Konishi N.

Cancer Sci. 2013 Mar;104(3):321-7. doi: 10.1111/cas.12089. Epub 2013 Feb 14.

PMID:
23279696
19.

Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.

Kubo N, Harada T, Anai S, Otsubo K, Yoneshima Y, Ijichi K, Koga T, Takayama K, Nakanishi Y.

Intern Med. 2012;51(17):2399-401. Epub 2012 Sep 1.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk